Informação sobre produto
Nome:
NAN-190 hydrobromide
Sinónimos:
- NAN 190
- 1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-, monohydrobromide
- 1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-, hydrobromide (1:1)
- 2-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]-1H-isoindole-1,3(2H)-dione hydrobromide (1:1)
- 2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-isoindoline-1,3-dione hydrobromide
Descrição:
NAN-190 hydrobromide is an experimental drug that is a 5-HT7 receptor antagonist. It has been shown to inhibit the activity of 5-HT7 receptors in rat and human bladder cancer cells. NAN-190 hydrobromide also inhibits the growth of prostate cancer cells and reduces tumour size in mice. NAN-190 hydrobromide is a potent antagonist at both the 5-HT1A and 5-HT2A receptors, which are associated with anxiety and depression, respectively. This compound has not been tested on humans, but it has caused adverse effects in animals such as decreased locomotor activity and weight loss.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
474.39 g/mol
Fórmula:
C23H28BrN3O3
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
